Investigators highlighted CXCL1EV-dead as a novel dying cell-released signal and provided TPCA-1 as a targeting candidate to improve TNBC prognosis.
[Journal Of Experimental & Clinical Cancer Research]
Chemotherapy-Elicited Extracellular Vesicle CXCL1 From Dying Cells Promotes Triple-Negative Breast Cancer Metastasis by Activating TAM/PD-L1 Signaling
